テクノロジー プレゼンテーション
| 日時 | 2023年10月5日（木）14:00～14:30 |
|---|---|
| 会場 | 一橋講堂 |
| 演題 | Illumina technology improvements driving genomic insights |
| 演者 | Anthony Beckhouse Staff Reg Segment Marketing Manager Illumina, Inc., Product Marketing |
| 要旨 | Over the last several years many health challenges were magnified due to the pandemic, driving historic innovation across the global scientific community. In particular, the crucial role that genomics can play in transforming precision medicine and care delivery came to the forefront. From vaccines and therapies to early cancer detection and diagnostics, there was greater adoption of genomic medicine in than the last year than ever before in history – and this is just the beginning. Technologic advancements in sequencing by synthesis (SBS) chemistry and bioinformatics, together with long read sequencing assays through Illumina Complete Long Reads that can deliver contiguous data up to 10Kb, expands the breadth of applications on Illumina platforms by enabling the most accurate and comprehensive view of the genome, including SNPs, indels and structural variants that will fuel the next era of genomic medicine. In this presentation we will describe the technical innovations that are driving improvements in next generation sequencing capabilities on the NovaSeq™ X and highlight how this technology enables precision medicine applications. |